Original title: Beyond Malodor: A Multinational Patient-Reported Study of the Diagnostic, Psychosocial, and Cognitive Burden of Trimethylaminuria
Luz Ayda Gomez Lopez, Sang Sun Yoon, Vanessa Munoz Espana, Carolina Valero Walteros · September 2026
Trimethylaminuria, or TMAU, is a rare metabolic condition where the body cannot properly break down a smelly compound called trimethylamine. This buildup causes a strong body odor, but doctors know little about how it affects daily life. To find out, researchers surveyed people worldwide living with the condition. They discovered that the problem goes far beyond physical odor. Most patients never received an official medical diagnosis or explanation. Life was deeply affected for the vast majority: people experienced physical rejection, social exclusion, bullying, and major setbacks in school and work. Most also felt existing treatments simply do not work well enough. Furthermore, when researchers checked on thinking skills, most patients reported frequent, moderate or severe cognitive difficulties that interfered with their daily routines, work, or studies. The researchers concluded that TMAU needs earlier diagnosis, multidisciplinary care, and new treatments focused on life quality.
Imagine you are known in your neighborhood for a noisy lawnmower that you cannot fix. People avoid you, and children make fun. Then you start forgetting appointments and losing your keys, and everyone assumes it is because you are lazy. In this paper, the noise is the body odor from trimethylaminuria, the social rejection is the exclusion patients face, and the forgotten keys are the cognitive symptoms that turn out to be part of the same condition, not a separate weakness.
People with trimethylaminuria, a rare metabolic disorder, often struggle not only with body odor but also with memory, focus, and thinking. This study shows that most patients face these cognitive problems weekly, yet they are rarely addressed. Recognizing these symptoms could improve patient care and quality of life.
The study relies entirely on patient self-report via an online survey, which may introduce recall bias and selection bias (e.g., those with more severe symptoms might be more likely to participate). Cognitive symptoms were assessed subjectively without standardized neuropsychological testing. The study is cross-sectional, so it cannot establish cause-and-effect relationships between TMAU and cognitive difficulties. No comparison group (e.g., healthy controls) was included.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
Beyond Malodor: A Multinational Patient-Reported Study of the Diagnostic, Psychosocial, and Cognitive Burden of Trimethylaminuria — Luz Ayda Gomez Lopez, Sang Sun Yoon, Vanessa Munoz Espana et al. — medRxiv — doi:10.64898/2026.09.08.26362298
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper. This is a preprint, so it hasn't necessarily been peer reviewed.